OMX Copenhagen 20
2.095,60
PKT
+75,49
PKT
+3,74
%
Werbung
Analysen zu OMX Copenhagen 20-Werten
Datum | Rating | Analyst | |
---|---|---|---|
17.10.17 | Novo Nordisk Equal-Weight | Morgan Stanley | |
17.10.17 | Novo Nordisk Reduce | HSBC | |
16.10.17 | Novo Nordisk Hold | Jefferies & Company Inc. | |
13.10.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
10.10.17 | Novo Nordisk Reduce | HSBC | |
09.10.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
25.09.17 | Novo Nordisk Neutral | BNP PARIBAS | |
18.09.17 | Novo Nordisk Hold | Jefferies & Company Inc. | |
13.09.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
07.09.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
06.09.17 | Novo Nordisk Neutral | Merrill Lynch & Co., Inc. | |
24.08.17 | Novo Nordisk Hold | Jefferies & Company Inc. | |
18.08.17 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
18.08.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
17.08.17 | Novo Nordisk buy | UBS AG | |
17.08.17 | Novo Nordisk Reduce | HSBC | |
17.08.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
15.08.17 | Novo Nordisk Neutral | Citigroup Corp. | |
11.08.17 | Novo Nordisk Neutral | Citigroup Corp. | |
10.08.17 | Novo Nordisk buy | Deutsche Bank AG | |
10.08.17 | Novo Nordisk buy | UBS AG | |
10.08.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
10.08.17 | Novo Nordisk Underweight | Barclays Capital | |
10.08.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
10.08.17 | Novo Nordisk Reduce | HSBC | |
09.08.17 | Novo Nordisk Hold | S&P Capital IQ | |
04.08.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
01.08.17 | Novo Nordisk buy | Deutsche Bank AG | |
01.08.17 | Novo Nordisk buy | UBS AG | |
26.07.17 | Novo Nordisk buy | UBS AG | |
21.07.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
07.07.17 | Novo Nordisk buy | Deutsche Bank AG | |
30.06.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
27.06.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
26.06.17 | Novo Nordisk Neutral | Citigroup Corp. | |
21.06.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
19.06.17 | Novo Nordisk Neutral | Citigroup Corp. | |
19.06.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
16.06.17 | Novo Nordisk Hold | Jefferies & Company Inc. | |
14.06.17 | Novo Nordisk buy | Goldman Sachs Group Inc. |